RAFFLESINTERIOR (01376) Announcement of suspension for trading on November 25th pending the announcement of the establishment of an investigation committee and the appointment of external forensic experts to conduct an internal investigation.
RAFFLESINTERIOR (01376) announced that the company's shares will be suspended from November 25, 2025...
RAFFLESINTERIOR (01376) announced that trading of the company's shares on The Stock Exchange of Hong Kong Limited will be suspended starting from 9:00 am on November 25, 2025, pending the establishment of an investigation committee and the engagement of external forensic experts to conduct an internal investigation (constituting insider information).
Related Articles

Vitasoy International Holdings Limited (00345) will distribute an interim dividend of 4 Hong Kong cents per share on December 23rd.
.png)
Vitasoy International Holdings Limited (00345) announces its interim results with a profit attributable to equity holders of HK $172 million, representing a 1% year-on-year growth. Dividend per share is 4 HK cents.

CSTONE PHARMA-B(02616)The EU Commission approves the use of Sugriva monoclonal antibody for the treatment of stage III non-small cell lung cancer.
Vitasoy International Holdings Limited (00345) will distribute an interim dividend of 4 Hong Kong cents per share on December 23rd.

Vitasoy International Holdings Limited (00345) announces its interim results with a profit attributable to equity holders of HK $172 million, representing a 1% year-on-year growth. Dividend per share is 4 HK cents.
.png)
CSTONE PHARMA-B(02616)The EU Commission approves the use of Sugriva monoclonal antibody for the treatment of stage III non-small cell lung cancer.






